RE:RE:RE:RE:RE:RE:Random Thought...Benedictus wrote: All very valid points KC and you may be on the money with your guess...but why do a placement for $32M of acquisition capital and then increase the shelf prospectus, which as we know brings in the shorts and caps the share price.
It could be setting up a poison pill strategy to fend off a takeover attempt by allowing all other shareholders to buy at a discount.